Search Results for: TRAF6

Novel Symbol Description Pathways Hide Drugs Hide Diseases Hide
TLR3 toll like receptor 3
  • Trafficking and processing of endosomal TLR
  • Toll Like Receptor 3 (TLR3) Cascade
  • TICAM1, RIP1-mediated IKK complex recruitment
  • RIP-mediated NFkB activation via ZBP1
  • TLR3 deficiency - HSE
  • UNC93B1 deficiency - HSE
  • TICAM1 deficiency - HSE
  • TRAF3 deficiency - HSE
  • TLR3-mediated TICAM1-dependent programmed cell death
  • TICAM1-dependent activation of IRF3/IRF7
  • TICAM1,TRAF6-dependent induction of TAK1 complex
  • Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation
  • RSV-host interactions
TNFAIP3 TNF alpha induced protein 3
  • NOD1/2 Signaling Pathway
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • Ovarian tumor domain proteases
  • Negative regulators of DDX58/IFIH1 signaling
TNFRSF11A TNF receptor superfamily member 11a
  • TNFR2 non-canonical NF-kB pathway
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • ENMD-1198
  • Osteopetrosis, including: Osteopetrosis, severe neonatal or infantile forms; Osteopetrosis, intermediate forms; Osteopetrosis with renal tubular acidosis; Osteopetrosis, late-onset form type 1; Osteopetrosis, late-onset form type 2; Osteopetrosis, osteoclast poor
  • Paget's disease of bone and related disorders, including: ; Paget's disease of bone (PDB); Familial expansile osteolysis (FEO); Early-onset Paget's disease of bone (PDB2); Expansile skeletal hyperphosphatasia (ESH); Juvenile Paget's disease (JPD)
TNFRSF13B TNF receptor superfamily member 13B
  • TNFs bind their physiological receptors
  • Common variable immunodeficiency (CVID), including the following four diseases: Inducible T Cell costimulator (ICOS) defect; TACI defect; CD19 defect; BAFFR defect
TNFRSF19 TNF receptor superfamily member 19
TNFSF11 TNF superfamily member 11
  • TNFR2 non-canonical NF-kB pathway
  • TNFs bind their physiological receptors
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Transcriptional and post-translational regulation of MITF-M expression and activity
  • Lenalidomide
  • AMGN-0007
  • Denosumab
  • Thiocolchicoside
  • Osteopetrosis, including: Osteopetrosis, severe neonatal or infantile forms; Osteopetrosis, intermediate forms; Osteopetrosis with renal tubular acidosis; Osteopetrosis, late-onset form type 1; Osteopetrosis, late-onset form type 2; Osteopetrosis, osteoclast poor
TRAF1 TNF receptor associated factor 1
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
TRAF2 TNF receptor associated factor 2
  • Caspase activation via Death Receptors in the presence of ligand
  • Regulation by c-FLIP
  • RIPK1-mediated regulated necrosis
  • CASP8 activity is inhibited
  • TNFR1-induced proapoptotic signaling
  • Regulation of TNFR1 signaling
  • TNFR1-induced NF-kappa-B signaling pathway
  • TNFR2 non-canonical NF-kB pathway
  • Regulation of necroptotic cell death
  • TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway
  • Ub-specific processing proteases
  • Dimerization of procaspase-8
  • TNF signaling
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • TRAF6 mediated NF-kB activation
  • Defective RIPK1-mediated regulated necrosis
  • Regulation of NF-kappa B signaling
TRAF3IP1 TRAF3 interacting protein 1
  • Intraflagellar transport
  • Intraflagellar transport
TRAF3IP2 TRAF3 interacting protein 2
TRAF4 TNF receptor associated factor 4
TRAF5 TNF receptor associated factor 5
TRAF7 TNF receptor associated factor 7
  • Antigen processing: Ubiquitination & Proteasome degradation
TRAFD1 TRAF-type zinc finger domain containing 1
TRAM1 translocation associated membrane protein 1
  • SRP-dependent cotranslational protein targeting to membrane
TRIM17 tripartite motif containing 17
  • Interferon gamma signaling
TRIM25 tripartite motif containing 25
  • ISG15 antiviral mechanism
  • DDX58/IFIH1-mediated induction of interferon-alpha/beta
  • Termination of translesion DNA synthesis
  • Ovarian tumor domain proteases
  • Interferon gamma signaling
  • TRAF3-dependent IRF activation pathway
  • TRAF6 mediated IRF7 activation
  • TRAF6 mediated NF-kB activation
  • TRAF6 mediated NF-kB activation
  • NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10
  • Negative regulators of DDX58/IFIH1 signaling
  • Negative regulators of DDX58/IFIH1 signaling
  • SARS-CoV-1 activates/modulates innate immune responses
  • SARS-CoV-2 activates/modulates innate and adaptive immune responses
  • Evasion by RSV of host interferon responses
  • RSV-host interactions
  • PKR-mediated signaling
  • Modulation of host responses by IFN-stimulated genes
TRIM37 tripartite motif containing 37
  • Antigen processing: Ubiquitination & Proteasome degradation
TTC3 tetratricopeptide repeat domain 3
TXNIP thioredoxin interacting protein
  • The NLRP3 inflammasome
  • The NLRP3 inflammasome
  • Regulation of FOXO transcriptional activity by acetylation
  • Purinergic signaling in leishmaniasis infection
  • Purinergic signaling in leishmaniasis infection
  • Cytoprotection by HMOX1

Page 8 out of 10 pages